Equity Profile

NOVT

Novanta Inc.

Information TechnologyElectronic Equipment & Instruments$5.6B

May11Mon

Post-Earnings Recap

ReportedQ1-2026After Close4:45 PM EDT

Novanta Inc. Beats on EPS, Stock Up 1.21%

Metric	Actual	Expected	Surprise
EPS	$0.81	$0.78	+5.19%
Revenue	N/A	$253M	N/A

management commentary, guidance changes, and full analysis available with Pro.

Novanta Inc. Beats on EPS, Stock Up 1.21%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$0.81	$0.78	+5.19%
Revenue	N/A	$253M	N/A

Management Commentary

Tone: Unknown

No transcript is on record for this earnings call, so the analysis is based solely on numerical results.

What It Means

Novanta Inc. reported better-than-expected earnings per share, which contributed to a positive stock reaction, with shares rising by 1.21%. However, revenue figures were not disclosed, leaving some uncertainty about overall performance. Investors may be encouraged by the EPS beat, but the lack of revenue data and guidance could lead to cautious sentiment moving forward.

Company Snapshot

Novanta Inc. operates in the Information Technology sector, focusing on electronic equipment and instruments....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well Novanta is managing costs and generating income.

0.78

Revenue

Revenue growth is crucial for assessing the company's ability to expand and capture market share, especially in competitive sectors.

253M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Novanta Inc. operates in the Information Technology sector, focusing on electronic equipment and instruments. The company is significant for its role in providing precision motion and photonics solutions, which are essential for various high-tech industries, including medical technology and automation.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+4.90%

Avg Stock Reaction

+0.95%

Last Quarter Recap

In the last quarter, Novanta reported an EPS of $0.91, exceeding expectations by 3.41%. However, the stock experienced a decline of 2.45% the following day, indicating mixed market reactions.

Management Promises & Guidance

Focus on enhancing product innovation.
Commitment to improving operational efficiencies.
Plans to expand into new markets.

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about Novanta's upcoming earnings, expecting a slight increase in both EPS and revenue. The company has a strong history of beating earnings expectations, which could lead to positive market reactions.

Bull Case

If Novanta beats the EPS estimate and shows strong revenue growth, it could signal robust demand for its products, leading to a significant stock price increase.

Bear Case

Conversely, if the company misses its earnings targets or provides weak guidance, it could raise concerns about its growth prospects, resulting in a sharp decline in stock value.

Key Metrics to Watch

EPS

0.78

Earnings per share is a key indicator of profitability and will show how well Novanta is managing costs and generating income.

Revenue

253M

Revenue growth is crucial for assessing the company's ability to expand and capture market share, especially in competitive sectors.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Novanta achieve an EPS of $0.78 or higher?

This figure is critical as it will indicate whether the company continues its trend of beating earnings expectations, which could influence investor confidence.

What is the revenue growth rate compared to the consensus of $253M?

Revenue performance is essential for assessing the company's market position and future growth potential, especially in a competitive landscape.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Novanta's ability to innovate and capture new markets, particularly in the medical technology sector.

Supporting Evidence

The company has consistently beaten EPS estimates in recent quarters, indicating strong management performance.

Options pricing suggests a higher expected move than historical averages, indicating potential for significant market reaction.

Insider selling may reflect strategic positioning rather than lack of confidence in the company’s future.

Key Risk

If revenue growth exceeds $255M, it could challenge the current cautious outlook and shift investor sentiment positively.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Novanta can maintain its growth momentum amidst competitive pressures and economic conditions.

Bull Confirmed If

An EPS of $0.80 or higher with revenue exceeding $255M would confirm strong operational performance.

Bear Confirmed If

An EPS below $0.76 or revenue falling short of $252M would raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±9.27%

Historical Avg

±5.1%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±8.1% while NOVT has averaged ±5.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.0%

30d HV

44.4%

Calls (19K)P/C Ratio: 0.31Puts (3K)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$845,325.00

6,500 sh

1 insider

Net

$845,325.00

Net selling

Most Active Insiders· 1 open-market trade

Chief Executive OfficerGlastra Matthijs
$845,325.00

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Novanta beats expectations, history suggests the stock could rise by around 1.75%, confirming strong demand and operational efficiency.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious investor sentiment.

Miss

If the company misses its targets, history suggests a potential decline of about 5.45%, which could raise concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations.
2Insights into market demand, particularly in medical technology.
3Management's commentary on operational efficiencies and cost management.
4Guidance on revenue expectations for the upcoming quarters.
5Responses to competitive pressures in the electronic equipment sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

EchoStar Corporation

Company Snapshot

Novanta Inc. operates in the Information Technology sector, focusing on electronic equipment and instruments....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well Novanta is managing costs and generating income.

0.78

Revenue

Revenue growth is crucial for assessing the company's ability to expand and capture market share, especially in competitive sectors.

253M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+4.90%

Avg Stock Reaction

+0.95%

Last Quarter Recap

In the last quarter, Novanta reported an EPS of $0.91, exceeding expectations by 3.41%. However, the stock experienced a decline of 2.45% the following day, indicating mixed market reactions.

Management Promises & Guidance

Focus on enhancing product innovation.
Commitment to improving operational efficiencies.
Plans to expand into new markets.

Expectations

Wall Street Expectations

Bull Case

If Novanta beats the EPS estimate and shows strong revenue growth, it could signal robust demand for its products, leading to a significant stock price increase.

Bear Case

Conversely, if the company misses its earnings targets or provides weak guidance, it could raise concerns about its growth prospects, resulting in a sharp decline in stock value.

Key Metrics to Watch

EPS

0.78

Earnings per share is a key indicator of profitability and will show how well Novanta is managing costs and generating income.

Revenue

253M

Revenue growth is crucial for assessing the company's ability to expand and capture market share, especially in competitive sectors.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Novanta achieve an EPS of $0.78 or higher?

This figure is critical as it will indicate whether the company continues its trend of beating earnings expectations, which could influence investor confidence.

What is the revenue growth rate compared to the consensus of $253M?

Revenue performance is essential for assessing the company's market position and future growth potential, especially in a competitive landscape.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Novanta's ability to innovate and capture new markets, particularly in the medical technology sector.

Supporting Evidence

The company has consistently beaten EPS estimates in recent quarters, indicating strong management performance.

Options pricing suggests a higher expected move than historical averages, indicating potential for significant market reaction.

Insider selling may reflect strategic positioning rather than lack of confidence in the company’s future.

Key Risk

If revenue growth exceeds $255M, it could challenge the current cautious outlook and shift investor sentiment positively.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Novanta can maintain its growth momentum amidst competitive pressures and economic conditions.

Bull Confirmed If

An EPS of $0.80 or higher with revenue exceeding $255M would confirm strong operational performance.

Bear Confirmed If

An EPS below $0.76 or revenue falling short of $252M would raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±9.27%

Historical Avg

±5.1%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±8.1% while NOVT has averaged ±5.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.0%

30d HV

44.4%

Calls (19K)P/C Ratio: 0.31Puts (3K)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$845,325.00

6,500 sh

1 insider

Net

$845,325.00

Net selling

Most Active Insiders· 1 open-market trade

Chief Executive OfficerGlastra Matthijs
$845,325.00

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Novanta beats expectations, history suggests the stock could rise by around 1.75%, confirming strong demand and operational efficiency.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious investor sentiment.

Miss

If the company misses its targets, history suggests a potential decline of about 5.45%, which could raise concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations.
2Insights into market demand, particularly in medical technology.
3Management's commentary on operational efficiencies and cost management.
4Guidance on revenue expectations for the upcoming quarters.
5Responses to competitive pressures in the electronic equipment sector.